1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 CMO/CDMO TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2017-2021
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 DEVELOPMENT
5.6 API PRODUCTION
5.7 FORMULATION
6 CMO/CDMO MARKET PRODUCT ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET PRODUCT ANALYSIS, 2017-2021
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 HAIR PRODUCTS
6.6 SKIN PRODUCTS
6.7 LIP PRODUCTS
6.8 EYE PRODUCTS
6.9 BODY HYGIENE
6.10 ORAL HYGIENE
7 CMO/CDMO MARKET SERVICE ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET SERVICE ANALYSIS, 2017-2021
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 CONTRACT DEVELOPMENT
7.5.1 FORMULATION DEVELOPMENT
7.5.2 PILOT STUDIES
7.6 CONTRACT MANUFACTURING
7.6.1 BULK PREPARATION & SCALE UP
7.6.2 SAFETY TESTING
7.6.3 FILLING & PACKAGING
7.6.4 CLOSE JARS
7.6.5 BOTTLES
7.6.6 TUBES
7.6.7 ROLL-ONS
7.6.8 OTHERS
8 CMO/CDMO MARKET FORM ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET FORM ANALYSIS, 2017-2021
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 SOLID FORM & POWDER
8.6 LOTIONS
8.7 CREAMS
8.8 OTHERS
9 CMO/CDMO MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2017-2021
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 PHARMACEUTICAL INDUSTRY
9.6 BIOTECHNOLOGY
9.7 OTHER
10 GLOBAL CMO/CDMO REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 SOUTH AMERICA
10.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 COUNTRY LEVEL ANALYSIS
11.1 UNITED STATES
11.2 CANADA
11.3 MEXICO
11.4 CHINA
11.5 JAPAN
11.6 INDIA
11.7 KOREA
11.8 SAUDI AREBIA
11.9 UAE
11.10 EGYPT
11.11 NIGERIA
11.12 SOUTH AFRICA
11.13 GERMANY
11.14 FRANCE
11.15 UK
11.16 RUSSIA
11.17 ITALY
11.18 BRAZIL
11.19 ARGENTINA
11.20 COLUMBIA
12 MARKET PLAYERS
12.1 SWISS AMERICAN CDMO
12.1.1 BUSINESS OVERVIEW:
12.1.2 PRODUCT PORTFOLIO
12.1.3 RECENT DEVELOPMENTS
12.1.4 SWOT ANALYSIS:
12.2 PIERRE FABRE GROUP
12.3 ZYMO COSMETICS
12.4 FAREVA
12.5 BIOFARMA SRL C.F.
12.6 CHEMINEAU
12.7 C.O.C. FARMACEUTICI SRL
12.8 PARAGON NORDIC
12.9 RECIPHARM
12.10 AMRI3
12.11 PATHEON
12.12 AENOVA
12.13 CATALENT
12.14 AMATSIGROUP
12.15 WUXI PHARMATECH
12.16 STRIDES SHASUN
12.17 PIRAMAL
12.18 SIEGFRIED
13 ABOUT US

TABLE 1 CMO/CDMO REGIONAL HISTORICAL MARKET ANALYSIS, 2017–2021 (USD MILLION)
TABLE 2 GLOBAL CMO/CDMO MARKET, 2022–2031, (USD MILLION)
TABLE 3 CMO/CDMO CURRENT AND FUTURE REGIONAL ANALYSIS, 2022–2031 (USD MILLION)
TABLE 4 GLOBAL CMO/CDMO HISTORICAL MARKET TYPE ANALYSIS, 2017-2021, (USD MILLION)
TABLE 5 CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 6 GLOBAL CMO/CDMO HISTORICAL MARKET PRODUCT ANALYSIS, 2017-2021, (USD MILLION)
TABLE 7 CMO/CDMO CURRENT AND FUTURE PRODUCT ANALYSIS, 2022–2031 (USD MILLION)
TABLE 8 GLOBAL CMO/CDMO HISTORICAL MARKET SERVICE ANALYSIS, 2017-2021, (USD MILLION)
TABLE 9 CMO/CDMO CURRENT AND FUTURE SERVICE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 10 GLOBAL CMO/CDMO HISTORICAL MARKET FORM ANALYSIS, 2017-2021, (USD MILLION)
TABLE 11 CMO/CDMO CURRENT AND FUTURE FORM ANALYSIS, 2022–2031 (USD MILLION)
TABLE 12 GLOBAL CMO/CDMO HISTORICAL MARKET APPLICATION ANALYSIS, 2017-2021, (USD MILLION)
TABLE 13 CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 14 NORTH AMERICA CMO/CDMO HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 15 NORTH AMERICA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 16 NORTH AMERICA CMO/CDMO CURRENT AND FUTURE PRODUCT ANALYSIS, 2022–2031 (USD MILLION)
TABLE 17 NORTH AMERICA CMO/CDMO CURRENT AND FUTURE SERVICE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 18 NORTH AMERICA CMO/CDMO CURRENT AND FUTURE FORM ANALYSIS, 2022–2031 (USD MILLION)
TABLE 19 NORTH AMERICA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 20 U.S. CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2017–2023
TABLE 21 U.S. CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 22 U.S. CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 23 CANADA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 24 CANADA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 25 MEXICO CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 26 MEXICO CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 27 APAC CMO/CDMO HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 28 ASIA-PACIFIC CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 29 ASIA-PACIFIC CMO/CDMO CURRENT AND FUTURE PRODUCT ANALYSIS, 2022–2031 (USD MILLION)
TABLE 30 ASIA-PACIFIC CMO/CDMO CURRENT AND FUTURE SERVICE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 31 ASIA-PACIFIC CMO/CDMO CURRENT AND FUTURE FORM ANALYSIS, 2022–2031 (USD MILLION)
TABLE 32 ASIA-PACIFIC CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 33 CHINA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 34 CHINA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 35 JAPAN CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 36 JAPAN CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 37 KOREA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 38 KOREA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 39 INDIA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 40 INDIA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 41 SOUTHEAST ASIA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 42 SOUTHEAST ASIA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA CMO/CDMO HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA CMO/CDMO CURRENT AND FUTURE PRODUCT ANALYSIS, 2022–2031 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA CMO/CDMO CURRENT AND FUTURE SERVICE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CMO/CDMO CURRENT AND FUTURE FORM ANALYSIS, 2022–2031 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 49 SAUDI ARABIA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 50 SAUDI ARABIA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 51 UAE CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 52 UAE CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 53 EGYPT CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 54 EGYPT CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 55 NIGERIA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 56 NIGERIA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 57 SOUTH AFRICA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 58 SOUTH AFRICA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 59 EUROPE CMO/CDMO HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 60 EUROPE CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 61 EUROPE CMO/CDMO CURRENT AND FUTURE PRODUCT ANALYSIS, 2022–2031 (USD MILLION)
TABLE 62 EUROPE CMO/CDMO CURRENT AND FUTURE SERVICE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 63 EUROPE CMO/CDMO CURRENT AND FUTURE FORM ANALYSIS, 2022–2031 (USD MILLION)
TABLE 64 EUROPE CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 65 GERMANY CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 66 GERMANY CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 67 FRANCE CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 68 FRANCE CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 69 UK CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 70 UK CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 71 RUSSIA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 72 RUSSIA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 73 ITALY CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 74 ITALY CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 75 SOUTH AMERICA CMO/CDMO HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 76 SOUTH AMERICA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 77 SOUTH AMERICA CMO/CDMO CURRENT AND FUTURE PRODUCT ANALYSIS, 2022–2031 (USD MILLION)
TABLE 78 SOUTH AMERICA CMO/CDMO CURRENT AND FUTURE SERVICE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 79 TABLE 82 SOUTH AMERICA CMO/CDMO CURRENT AND FUTURE FORM ANALYSIS, 2022–2031 (USD MILLION)
TABLE 80 SOUTH AMERICA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 81 BRAZIL CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 82 BRAZIL CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 83 ARGENTINA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 84 ARGENTINA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 85 COLUMBIA CMO/CDMO CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 86 COLUMBIA CMO/CDMO CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)